Bruker Highlights New Developments in 4D Proteomics and Functional Proteoform Analysis
Bruker Corporation has announced new developments in 4D proteomics performance, along with additional innovations in intact and top-down functional proteoform analysis technologies. According to the company, these advancements are intended to support deeper biological insights and improve analytical capabilities in proteomics and metabolomics research.
The announcement highlights continued progress in mass spectrometry workflows, including improvements in sensitivity, throughput, data analysis, and protein characterization. Bruker stated that its latest developments are designed to assist researchers working in disease biology, biomarker discovery, translational research, and multiomics applications.
Among the areas emphasized were:
- Enhanced 4D proteomics workflows
- Advances in intact protein and top-down proteoform analysis
- Expanded software and analytical capabilities
- Improved high-throughput performance for proteomics studies
- Additional innovations in metabolomics and related omics workflows
The company has continued investing in technologies related to collision cross section (CCS)-enabled analysis and timsTOF-based platforms, which have been increasingly adopted in advanced proteomics research environments.
This article is intended solely as an independent industry news summary based on publicly available information released by Bruker Corporation. All trademarks, product names, and company names mentioned are the property of their respective owners.
Original source:
Bruker official announcement
